The concept of cancer immune surveillance suggests that tumour progression is accompanied by an accumulation of immune escape factors, to the detriment of effector T-cell immunity.1,30 Therefore, we explored whether NSCLC stage progression was accompanied by changes in the anti-TERT Th1 response and the level of exhausted T cells. This evidence concerns the gene TERT and cancer.